Richy Agajanian - 10 Jun 2022 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
10%+ Owner
Signature
/s/ Richy Agajanian, M.D., for himself and as the President and Chief Executive Officer of Jimmy Holdings, Inc.
Issuer symbol
TOI
Transactions as of
10 Jun 2022
Net transactions value
-$1,545,000
Form type
4
Filing time
14 Jun 2022, 19:12:42 UTC
Previous filing
13 May 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOI Stock Option (right to buy) Sale $1,545,000 -300,000 -50% $5.15* 296,075 10 Jun 2022 Class A Common Stock 300,000 $0.8500 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Richy Agajanian is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These stock options were received by Dr. Agajanian's spouse on November 12, 2021 in connection with a business combination. As of that date, 459,475 of the options were vested and 136,600 remained subject to vesting at the rate of 12,418 options each month, subject to Dr. Agajanian's spouse's continued employment with the issuer.
F2 Held by Dr. Agajanian's spouse. The reporting persons disclaim beneficial ownership of these securities.